Brainreader, an Aalborg, Denmark-based medtech company, raised €6.6m in funding.
The round was led by Dahlgren Capital, with participation from continued support from existing backer Investo Capital.
The company intends to use the funds to expand its commercial operations.
Led by Mads Fiig, CEO, Brainreader provides Neuroreader®, a a CE-marked and FDA-cleared diagnostic platform that analyses MRI brain scans, compares the measured volumes with an age and gender matched population and provides a statistical variation analysis. This objective analysis enables the physicians to set an informed and more confident diagnosis sooner.
The system integrates directly into standard workflows.
FinSMEs
29/05/2025